Your browser doesn't support javascript.
loading
Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations.
Damerval, Margaux; Bennani, Mohammed; Rioufol, Catherine; Omrani, Selim; Riboulet, Margaux; Etienne-Selloum, Nelly; Saint-Ghislain, Audrey; Leenhardt, Fanny; Schmitt, Antonin; Simon, Nicolas; Clairet, Anne-Laure; Meurisse, Aurélia; Nerich, Virginie.
Afiliação
  • Damerval M; CHU Besançon, Pôle Pharmacie, 25030, Besançon, France.
  • Bennani M; Qualees, Paris, France.
  • Rioufol C; Department of Pharmacy, Hospices Civils de Lyon, UCBL1, EA3738 CICLY, F-69002, Lyon, France.
  • Omrani S; Department of Pharmacy, Hôpital Nord Franche-Comté, Site de Belfort, 90400, Trévenans, France.
  • Riboulet M; Assistance Pour Le Traitement des Urémiques en Provence-Corse, Centre de Néphrologie Marseille Borde, 13008, Marseille, France.
  • Etienne-Selloum N; Department of Pharmacy, Institut de Cancérologie Strasbourg Europe, 67200, Strasbourg, France.
  • Saint-Ghislain A; Laboratory of Bioimaging and Pathology, University of Strasbourg, UMR7021 CNRS, 67401, Illkirch, France.
  • Leenhardt F; Department of Pharmacy, Centre Hospitalier de Dunkerque, 59240, Dunkirk, France.
  • Schmitt A; Department of Pharmacy, Institut du Cancer de Montpellier, 34090, Montpellier, France.
  • Simon N; Department of Pharmacy, Centre Georges-François Leclerc, 21000, Dijon, France.
  • Clairet AL; Department of Pharmacy, Centre Hospitalier Universitaire de Lille, 59000, Lille, France.
  • Meurisse A; CHU Besançon, Pôle Pharmacie, 25030, Besançon, France.
  • Nerich V; Methodology and Quality of Life in Oncology Unit, Centre Hospitalier Universitaire de Besançon, 25000, Besançon, France.
Support Care Cancer ; 32(5): 318, 2024 Apr 30.
Article em En | MEDLINE | ID: mdl-38687392
ABSTRACT

PURPOSE:

To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. They are conditioned by the needs, expectations, and involvement of the patients in their care. Thus, it is essential to elicit their preferences. The discrete-choice experiment (DCE) is a method recommended by the ISPOR for such a task. The "selection and validation of attributes and their values" step is fundamental in this process. In this context, the aim of this study was to present our research approach to identify and validate the attributes that characterize an OPC and their values.

METHODS:

Due to the lack of relevant published data in the literature, the focus-group method was used in accordance with good research practices for the application of conjoint-analysis of the ISPOR. The two-round Delphi method was used to validate the attributes and their values identified by the focus-group method.

RESULTS:

The focus-group method enabled identification of nine attributes. Thirty-seven healthcare professionals at a national level, including 30 pharmacists and seven physicians, were selected to take part in the Delphi procedure. Seven attributes (frequency, planification, operation mode, duration, content, written support, and report) and their values were thus validated.

CONCLUSION:

Based on these results, the next step will be to elicit patient preferences for OPCs and to then shed light on the issues of pharmaceutical support for patients by comparing their preferences with those of informal caregivers and, in particular, those of the healthcare professionals involved in their care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento de Escolha / Técnica Delphi / Grupos Focais / Preferência do Paciente / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comportamento de Escolha / Técnica Delphi / Grupos Focais / Preferência do Paciente / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article